Cite
HARVARD Citation
Cohen, N. et al. (2020). Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study. United European Gastroenterology journal. 8 (9), pp. 1076-1085. [Online].